Connect Biopharma Holdings Ltd (CNTB) — Financial Flexibility Index
Connect Biopharma Holdings Ltd (CNTB) has a Financial Flexibility Index of -0.92x as of March 2026. Free cash flow of $-16.00 Million (operating CF $-16.00 Million minus capex $0.00) represents -1% of total liabilities ($17.44 Million). Check CNTB goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Connect Biopharma Holdings Ltd Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Connect Biopharma Holdings Ltd across 8 annual periods. For the full cash flow conversion analysis, see CNTB operating cash flow.
Annual Financial Flexibility Index for Connect Biopharma Holdings Ltd (2018–2025)
Year-by-year free cash flow to debt coverage for Connect Biopharma Holdings Ltd. Explore CNTB operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.60x | $-50.77 Million | $-51.21 Million | $14.10 Million | ▼ -43.7% |
| 2024 | -2.51x | $-22.86 Million | $-23.61 Million | $9.12 Million | ▼ -36.2% |
| 2023 | -1.84x | $-47.64 Million | $-47.93 Million | $25.88 Million | ▲ +68.0% |
| 2022 | -5.75x | $-94.99 Million | $-99.27 Million | $16.52 Million | ▲ +78.3% |
| 2021 | -26.46x | $-497.40 Million | $-544.93 Million | $18.80 Million | ▼ -5527.8% |
| 2020 | -0.47x | $-23.26 Million | $-25.61 Million | $49.47 Million | ▲ +49.4% |
| 2019 | -0.93x | $-12.94 Million | $-13.09 Million | $13.91 Million | ▼ -21.6% |
| 2018 | -0.76x | $-67.84 Million | $-69.03 Million | $88.70 Million | — |